Robert J. Gillies, PhD
Robert J. Gillies, PhD
Faculty Rank:
Senior Member
Titles:
-
Director, Molecular and Functional Imaging
-
Vice Chair, Radiology Research
Department/Program Affiliations:
-
Integrated Mathematical Oncology
-
Experimental Therapeutics
-
Diagnostic Imaging
Primary Address:
H. Lee Moffitt Cancer Center &
Research Institute
12902 Magnolia Drive
Tampa,
FL
33612
USF Affiliations/College Department:
-
Medicine / Oncologic Sciences
For corrections, please e-mail a request
Printer friendly version
Printer friendly version (including publications)
Robert J. Gillies, PhD
Education & Training:
-
BS, University of California, Irvine, 1974 - Biology
-
PhD, University of California, Davis, 1979 - Zoology
-
Fellowship, Yale University, 1982 - Molecular biophysics
For corrections, please e-mail a request
Printer friendly version
Printer friendly version (including publications)
Robert J. Gillies, PhD
Research Interests:
Dr. Gillies' current research projects are focused on the use of non-invasive imaging for cancer therapy and are divided into three interrelated areas; (1) The interrogation and modeling of the tumor microenvironment and its effect on tumor progression and therapy; (2) Development of multivalent targeting molecules for specific cancer imaging and delivery of therapy; (3) The use of imaging as a biomarker of therapy response.
For corrections, please e-mail a request
Printer friendly version
Printer friendly version (including publications)
Robert J. Gillies, PhD
Below is a list of active grants where the faculty member is the Principal Investigator. Grants are sorted by sponsor and then sorted by start date, with the more recent grant shown first.
Targeted Melanoma Therapies
Project Order #2
|
|
Sponsor:
|
Intezyne Technologies, Inc.
|
|
Project Dates:
|
July 1, 2010 to
June 30, 2011
|
|
Earned to Date:
|
$5,000
|
Radiology Report Abstraction Questionnaire Project (NO COST EXTENSION)
LKR53630, #06-0230
|
|
Sponsor:
|
Merck & Co., Inc. / Rosetta
|
|
Project Dates:
|
May 4, 2009 to
November 4, 2011
|
Project 2
5 U54 CA143970-02
|
|
Sponsor:
|
Nat Institutes of Health / NCI
|
|
Project Dates:
|
September 1, 2010 to
August 31, 2011
|
|
Earned to Date:
|
$583,326
|
Radiomics of NSCLC
1 U01 CA143062-01
|
|
Sponsor:
|
Nat Institutes of Health / NCI
|
|
Project Dates:
|
March 9, 2010 to
February 28, 2015
|
|
Annual Direct Cost:
|
$460,355
|
|
Annual Total Cost:
|
$621,495
|
|
Project Total:
|
$2,984,045
|
Causes and Consequences of Acid pH in Tumors
5 R01 CA077575-11
|
|
Sponsor:
|
Nat Institutes of Health / NCI
|
|
Project Dates:
|
September 29, 2009 to
July 31, 2014
|
|
Annual Direct Cost:
|
$289,284
|
|
Annual Total Cost:
|
$483,104
|
|
Project Total:
|
$2,460,158
|
Targeting Pancreatic Cancer
5 R01 CA123547-04
|
|
Sponsor:
|
Nat Institutes of Health / NCI
|
|
Project Dates:
|
August 13, 2009 to
June 30, 2012
|
|
Annual Direct Cost:
|
$394,769
|
|
Annual Total Cost:
|
$659,264
|
|
Project Total:
|
$1,984,608
|
Imaging Biomarkers for Anti-Cancer Therapy
5 R01 CA125627-03
|
|
Sponsor:
|
Nat Institutes of Health / NCI
|
|
Project Dates:
|
September 1, 2008 to
July 31, 2013
|
|
Annual Direct Cost:
|
$248,656
|
|
Annual Total Cost:
|
$334,138
|
|
Project Total:
|
$1,671,623
|
Multimeric Ligands for Targeting Melanoma
5 R01 CA097360-07
|
|
Sponsor:
|
Nat Institutes of Health / NCI
|
|
Project Dates:
|
August 8, 2008 to
May 31, 2013
|
|
Annual Direct Cost:
|
$509,032
|
|
Annual Total Cost:
|
$626,904
|
|
Project Total:
|
$3,176,243
|